Recent Progress on Tumor Microenvironment-Activated NIR-II Phototheranostic Agents with Simultaneous Activation for Diagnosis and Treatment

被引:5
作者
Xiao, Hao [1 ,2 ]
Wu, Gui-long [1 ,2 ]
Tan, Senyou [1 ,2 ]
Tan, Xiaofeng [1 ,2 ,3 ]
Yang, Qinglai [1 ,2 ,3 ]
机构
[1] Univ South China, Inst Pharm & Pharmacol, Sch Pharmaceut Sci, Hengyang Med Sch, 28 West Changsheng Rd, Hengyang City 421001, Hunan, Peoples R China
[2] Univ South China, Hengyang Med Sch, MOE Key Lab Rare Pediat Dis, 28 West Changsheng Rd, Hengyang City 421001, Hunan, Peoples R China
[3] Hunan Prov Maternal & Child Hlth Care Hosp, Key Lab Birth Defect Res & Prevent, Natl Hlth Commiss, 53 Xiangchun Rd, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor microenvironment factors; NIR-II phototheranostic agents; Simultaneous activation; Integration of diagnosis and treatment; CANCER-DIAGNOSIS; GLUTATHIONE; THERAPY; ACIDITY; SYSTEMS; STRESS; GROWTH; ROS;
D O I
10.1002/asia.202301036
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Malignant tumors seriously threaten human life and well-being. Emerging Near-infrared II (NIR-II, 1000-1700 nm) phototheranostic nanotechnology integrates diagnostic and treatment modalities, offering merits including improved tissue penetration and enhanced spatiotemporal resolution. This remarkable progress has opened promising avenues for advancing tumor theranostic research. The tumor microenvironment (TME) differs from normal tissues, exhibiting distinct attributes such as hypoxia, acidosis, overexpressed hydrogen peroxide, excess glutathione, and other factors. Capitalizing on these attributes, researchers have developed TME-activatable NIR-II phototheranostic agents with diagnostic and therapeutic attributes concurrently. Therefore, developing TME-activatable NIR-II phototheranostic agents with diagnostic and therapeutic activation holds significant research importance. Currently, research on TME-activatable NIR-II phototheranostic agents is still in its preliminary stages. This review examines the recent advances in developing dual-functional NIR-II activatable phototheranostic agents over the past years. It systematically presents NIR-II phototheranostic agents activated by various TME factors such as acidity (pH), hydrogen peroxide (H2O2), glutathione (GSH), hydrogen sulfide (H2S), enzymes, and their hybrid. This encompasses NIR-II fluorescence and photoacoustic imaging diagnostics, along with therapeutic modalities, including photothermal, photodynamic, chemodynamic, and gas therapies triggered by these TME factors. Lastly, the difficulties and opportunities confronting NIR-II activatable phototheranostic agents in the simultaneous diagnosis and treatment field are highlighted. This review examines the recent advances in developing dual-functional NIR-II activatable phototheranostic agents over the past years. It systematically presents NIR-II phototheranostic agents activated by various TME factors such as acidity (pH), hydrogen peroxide (H2O2), glutathione (GSH), hydrogen sulfide (H2S), enzymes, as well as multiple TME factors. image
引用
收藏
页数:13
相关论文
共 108 条
  • [1] Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
    Allemani, Claudia
    Weir, Hannah K.
    Carreira, Helena
    Harewood, Rhea
    Spika, Devon
    Wang, Xiao-Si
    Bannon, Finian
    Ahn, Jane V.
    Johnson, Christopher J.
    Bonaventure, Audrey
    Marcos-Gragera, Rafael
    Stiller, Charles
    Azevedo e Silva, Gulnar
    Chen, Wan-Qing
    Ogunbiyi, Olufemi J.
    Rachet, Bernard
    Soeberg, Matthew J.
    You, Hui
    Matsuda, Tomohiro
    Bielska-Lasota, Magdalena
    Storm, Hans
    Tucker, Thomas C.
    Coleman, Michel P.
    [J]. LANCET, 2015, 385 (9972) : 977 - 1010
  • [2] A minireview on multiparameter-activated nanodevices for cancer imaging and therapy
    Bai, Huarong
    Peng, Ruizi
    Wang, Dan
    Sawyer, Martin
    Fu, Ting
    Cui, Cheng
    Tan, Weihong
    [J]. NANOSCALE, 2020, 12 (42) : 21571 - 21582
  • [3] Methylglyoxal-derived stress: An emerging biological factor involved in the onset and progression of cancer
    Bellahcene, Akeila
    Nokin, Marie-Julie
    Castronovo, Vincent
    Schalkwijk, Casper
    [J]. SEMINARS IN CANCER BIOLOGY, 2018, 49 : 64 - 74
  • [4] Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer
    Bellier, Justine
    Nokin, Marie-Julie
    Larde, Eva
    Karoyan, Philippe
    Peulen, Olivier
    Castronovo, Vincent
    Bellahcene, Akeila
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 148 : 200 - 211
  • [5] The Acidic Tumor Microenvironment as a Driver of Cancer
    Boedtkjer, Ebbe
    Pedersen, Stine F.
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, VOL 82, 2020, 82 : 103 - 126
  • [6] Radioactive Transition Metals for Imaging and Therapy
    Boros, Eszter
    Packard, Alan B.
    [J]. CHEMICAL REVIEWS, 2019, 119 (02) : 870 - 901
  • [7] Tumor microenvironment and the response to anticancer therapy
    Brown, JM
    [J]. CANCER BIOLOGY & THERAPY, 2002, 1 (05) : 453 - 458
  • [8] Targeting mutant p53 for efficient cancer therapy
    Bykov, Vladimir J. N.
    Eriksson, Sofi E.
    Bianchi, Julie
    Wiman, Klas G.
    [J]. NATURE REVIEWS CANCER, 2018, 18 (02) : 89 - 102
  • [9] Regulation of cancer cell metabolism
    Cairns, Rob A.
    Harris, Isaac S.
    Mak, Tak W.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (02) : 85 - 95
  • [10] Responsive Theranostic Systems: Integration of Diagnostic Imaging Agents and Responsive Controlled Release Drug Delivery Carriers
    Caldorera-Moore, Mary E.
    Liechty, William B.
    Peppas, Nicholas A.
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2011, 44 (10) : 1061 - 1070